BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3131331)

  • 1. Proteolytic cleavage of the precursor of von Willebrand factor is not essential for multimer formation.
    Verweij CL; Hart M; Pannekoek H
    J Biol Chem; 1988 Jun; 263(17):7921-4. PubMed ID: 3131331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers.
    Wise RJ; Pittman DD; Handin RI; Kaufman RJ; Orkin SH
    Cell; 1988 Jan; 52(2):229-36. PubMed ID: 3124962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of variant von Willebrand factor (vWF) cDNA in heterologous cells: requirement of the pro-polypeptide in vWF multimer formation.
    Verweij CL; Hart M; Pannekoek H
    EMBO J; 1987 Oct; 6(10):2885-90. PubMed ID: 3500851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells.
    Voorberg J; Fontijn R; Calafat J; Janssen H; van Mourik JA; Pannekoek H
    EMBO J; 1993 Feb; 12(2):749-58. PubMed ID: 8440262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning, expression and assembly of multimeric von Willebrand factor.
    Pannekoek H; Voorberg J
    Baillieres Clin Haematol; 1989 Oct; 2(4):879-96. PubMed ID: 2688759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains involved in multimer assembly of von willebrand factor (vWF): multimerization is independent of dimerization.
    Voorberg J; Fontijn R; van Mourik JA; Pannekoek H
    EMBO J; 1990 Mar; 9(3):797-803. PubMed ID: 2311582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro multimerization of von Willebrand factor is triggered by low pH. Importance of the propolypeptide and free sulfhydryls.
    Mayadas TN; Wagner DD
    J Biol Chem; 1989 Aug; 264(23):13497-503. PubMed ID: 2788160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for extracellular processing of pro-von Willebrand factor after infusion in animals with and without severe von Willebrand disease.
    Turecek PL; Pichler L; Auer W; Eder G; Varadi K; Mitterer A; Mundt W; Schlokat U; Dorner F; Drouet LO; Roussi J; van Mourik JA; Schwarz HP
    Blood; 1999 Sep; 94(5):1637-47. PubMed ID: 10477688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
    Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure of pre-pro-von Willebrand factor and its expression in heterologous cells.
    Bonthron DT; Handin RI; Kaufman RJ; Wasley LC; Orr EC; Mitsock LM; Ewenstein B; Loscalzo J; Ginsburg D; Orkin SH
    Nature; 1986 Nov 20-26; 324(6094):270-3. PubMed ID: 3491324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vicinal cysteines in the prosequence play a role in von Willebrand factor multimer assembly.
    Mayadas TN; Wagner DD
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3531-5. PubMed ID: 1565649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro processing of recombinant pro-von Willebrand factor.
    Turecek PL; VĂ¡radi K; Schlokat U; Pichler L; Dorner F; Schwarz HP
    Histochem Cell Biol; 2002 Feb; 117(2):123-9. PubMed ID: 11935288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly and routing of von Willebrand factor variants: the requirements for disulfide-linked dimerization reside within the carboxy-terminal 151 amino acids.
    Voorberg J; Fontijn R; Calafat J; Janssen H; van Mourik JA; Pannekoek H
    J Cell Biol; 1991 Apr; 113(1):195-205. PubMed ID: 2007623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of specific storage organelles by von Willebrand factor propolypeptide.
    Wagner DD; Saffaripour S; Bonfanti R; Sadler JE; Cramer EM; Chapman B; Mayadas TN
    Cell; 1991 Jan; 64(2):403-13. PubMed ID: 1988154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor proteolytic processing and multimerization precede the formation of Weibel-Palade bodies.
    Vischer UM; Wagner DD
    Blood; 1994 Jun; 83(12):3536-44. PubMed ID: 8204880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor storage requires intact prosequence cleavage site.
    Journet AM; Saffaripour S; Cramer EM; Tenza D; Wagner DD
    Eur J Cell Biol; 1993 Feb; 60(1):31-41. PubMed ID: 8462598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PACE4 is a member of the mammalian propeptidase family that has overlapping but not identical substrate specificity to PACE.
    Rehemtulla A; Barr PJ; Rhodes CJ; Kaufman RJ
    Biochemistry; 1993 Nov; 32(43):11586-90. PubMed ID: 8218226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II.
    Fay PJ; Kawai Y; Wagner DD; Ginsburg D; Bonthron D; Ohlsson-Wilhelm BM; Chavin SI; Abraham GN; Handin RI; Orkin SH
    Science; 1986 May; 232(4753):995-8. PubMed ID: 3486471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes.
    Rehemtulla A; Kaufman RJ
    Blood; 1992 May; 79(9):2349-55. PubMed ID: 1571548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent fates of von Willebrand factor and its propolypeptide (von Willebrand antigen II) after secretion from endothelial cells.
    Wagner DD; Fay PJ; Sporn LA; Sinha S; Lawrence SO; Marder VJ
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):1955-9. PubMed ID: 3494248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.